Skip to content

APOTHEEK WILDERT

Active
Private limited companyfounded 2003active for 23 yearsSint-Jansstraat 28B, 2910 Essen, BelgiumKBO/BCE: BE 0479.870.876

From the official registers: KBO 23 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

APOTHEEK WILDERT has been active since 2003 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €427,175 and a net result of €105,170. Equity is growing by about 7.3% per year across the filed financial years. Its solvency ranks better than 52% of 12,737 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Risk analysisFollow ReportCompare
APOTHEEK WILDERTActiveChecked score 95/100
Risk analysis ReportCompare

Overview

Official details

KBO
Status
Active since 28-03-2003 Normal situation
Legal form
Private limited company
Registered office
Sint-Jansstraat 28B, 2910 Essen
Activity
Retail sale of pharmaceutical products NACE 47730
Establishment unit
2.126.658.187 2910 Essen, since 29-04-2003
Financial year end
31 December
Peppol
Reachable since 08-01-2026
Company details

Who decides

Board
  • Rosalex BVDirector · since 01-01-2017
Shareholders
Board & ownership

How it is doing

95 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.1%
Annual accounts 2025
Gross margin
€274,881
▼ 4.5%
Turnover
≈ €1.0m
estimated
Profit
€105,170
▲ 29.4%
Equity
€427,175
=
Total assets
€1.1m
▼ 4.2%
Staff
1.9 FTE
▼ 17.4%
2025 accounts filed 7 days late
Filed on 07-08-2026at the National Bank
Financials
Why 95raises riskSector: Retail trade (NACE 47)lowers riskLiquidity: current ratio 2.33, cash €334,731Founded in 2003Size: 1.9 FTE, total assets €1.1mShow the evidence

Checked score

Score 2025
95 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 62% of its sector peers (NACE 47, micro)
Every signal that counts is listed under Signals.
Financial strength · tick = 2024
Strong
Solvency 64+2
equity 38.7% of total assets
Liquidity 77+12
short-term debt 26.7% · cash 30.3%
Profitability 81+3
return on assets 9.5%
Bankruptcy probability, 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,270 companies, NACE 47, micro)
Last 24 months 11-2024: 0.1% 12-2024: 0.1%● unchanged vs 11-2024 01-2025: 0.1%● unchanged vs 12-2024 02-2025: 0.1%● unchanged vs 01-2025 03-2025: 0.1%● unchanged vs 02-2025 04-2025: 0.1%● unchanged vs 03-2025 05-2025: 0.1%● unchanged vs 04-2025 06-2025: 0.1%● unchanged vs 05-2025 07-2025: 0.1%● unchanged vs 06-2025 08-2025: 0.3%▲ +0.2 percentage points vs 07-2025 09-2025: 0.1%▼ -0.2 percentage points vs 08-2025 10-2025: 0.1%● unchanged vs 09-2025 11-2025: 0.1%● unchanged vs 10-2025 12-2025: 0.1%● unchanged vs 11-2025 01-2026: 0.1%● unchanged vs 12-2025 02-2026: 0.1%● unchanged vs 01-2026 03-2026: 0.1%● unchanged vs 02-2026 04-2026: 0.1%● unchanged vs 03-2026 05-2026: 0.1%● unchanged vs 04-2026 06-2026: 0.1%● unchanged vs 05-2026 07-2026: 0.1%● unchanged vs 06-2026 08-2026: 0.3%▲ +0.2 percentage points vs 07-2026highest value 09-2026: 0.1%▼ -0.2 percentage points vs 08-2026lowest value 10-2026: 0.1%● unchanged vs 09-2026lowest value
Credit of up to €40,000 on 30-day terms is acceptable
Liquidity ample (current ratio 2.33, compared with 2.39 in 2024, above the usual 1.5; short-term debt: 26.7% and cash: 30.3% of total assets), but 61.3% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro): better than 54% on solvency, 82% on liquidity, 72% on profitability and 39% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskraises risk
lowers risk · Liquidity: current ratio 2.33, cash €334,731
NBB · annual accounts
lowers risk · Founded in 2003
Companies that have existed this long fail less often; how much that weighs depends on the rest of its profile.
KBO
lowers risk · Size: 1.9 FTE, total assets €1.1m
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
raises risk · Sector: Retail trade (NACE 47)
KBO
raises risk · 2025 accounts filed 7 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 07-08-2026, 7 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 10 filings
Deviation from the deadline
2025
7 days late
2024
5 days late
2023
15 days late
2022
9 days early
2021
19 days late
2020
18 days late
2019
9 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 7 days after the deadline; the sector median (NACE 47) for financial year 2024 is on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 7 August (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
31-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage

Key points

  • Positive: 8 profitable years in a rowprofit 2025: €105,170 8 years View

Documents

Annual accounts at the NBB

All 23 annual accounts

Acts in the Belgian Official Gazette

All publications in the Belgian Official Gazette

Articles and registers

Key facts about APOTHEEK WILDERT

What is the company number of APOTHEEK WILDERT?
0479.870.876. In Belgium the VAT number is the company number with BE in front: BE 0479.870.876.
Where is APOTHEEK WILDERT based?
The registered office is at Sint-Jansstraat 28B, 2910 Essen.Company details
What does APOTHEEK WILDERT do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of APOTHEEK WILDERT?
Private limited company (BV).
When was APOTHEEK WILDERT founded?
On 28-03-2003.
Is APOTHEEK WILDERT still active?
Yes, APOTHEEK WILDERT is an active enterprise in the KBO register.
How many employees does APOTHEEK WILDERT have?
On average 1.9 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of APOTHEEK WILDERT?
≈ €1.0m in financial year 2025. Estimated from the gross margin of €274,881: probably between €780,000 and €1.6m, based on 47 comparable companies, NACE 477.
Is APOTHEEK WILDERT profitable?
In financial year 2025, APOTHEEK WILDERT made a profit of €105,170.
Where can I find the annual accounts of APOTHEEK WILDERT?
APOTHEEK WILDERT filed 23 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts at the National Bank
When are the next annual accounts of APOTHEEK WILDERT due?
By 31-07-2027, for financial year 2026.Timeline

Companies related to APOTHEEK WILDERT

Go further with this company

How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check What support did similar companies receive that this one did not?Subsidies How does this company compare with its sector?Sector benchmark

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure